INSEAD Day 4 - 728x90

Company News, Business, Economy, Health

Google to invest $6.4bn

The investment is its biggest-ever in Germany.

Pfizer poised to buy Metsera

The pharma giant improved its offer to $10bn.

Ozempic maker lowers outlook

The company posted tepid Q3 results.

Kimberly-Clark to buy Kenvue

The deal is valued at $48.7 billion.

BYD Q3 profit down 33%

This was a 33% year-on-year decrease.

AstraZeneca buys US firm CinCor

AstraZeneca forecast that total revenues would climb between one and five percent this year. (AFP)
By TRENDS Desk AFP
January 9, 2023 4:59 pm
  • The takeover marks the latest push by Astra chief executive Pascal Soriot to bolster the company's pipeline of new products.
  • Massachusetts-based CinCor focuses on developing treatments for hypertension and chronic kidney disease.

LONDON, UK –  Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for US$1.8 billion, expanding further into the field of heart and kidney drugs.

The takeover marks the latest push by Astra chief executive Pascal Soriot to bolster the company’s pipeline of new products.

Massachusetts-based CinCor focuses on developing treatments for hypertension and chronic kidney disease.

Since taking the helm at AstraZeneca in 2012, Frenchman Soriot has expanded the company into lucrative cancer therapies.

The group completed a blockbuster takeover of Alexion for $39 billion in 2021, giving it more heft in areas such as treating blood disorders.

[adinserter block="5"]

Most Read

Future of Humanity – TRENDS’ yearly Special Issue now online

Dubai, UAE — TRENDS’ yearly Special Issue is out. This year’s edition, titled Future of Humanity, explores key global shifts and brings together expert insights on old and new forces…

10,000 deaths raise specter of genocide in Gaza

Some world leaders like Turkey's President Erdogan use the term genocide to describe Israeli actions in Gaza. Israel has also been accused of war crimes by rights organizations.

NYU Abu Dhabi team develops wireless pill to control gut neurons

Abu Dhabi, UAE — Researchers at NYU Abu Dhabi (NYUAD) have developed an ingestible device that uses light to activate neurons in the gut. This new technology, called ICOPS (Ingestible…

Alphabet posts first $100 bn quarter

The growth was powered by cloud division buoyed by AI

35.6% rise in Saudi women’s economic participation makes TOP CEO Conference’s May predictions true

The confirmation of an increased participation of women in workplace comes months after the TOP CEO Conference held in May 2022 had highlighted its economic justifications.

INSEAD Day 4- 300x600
INSEAD Day 4- 300x600
[adinserter block="4"]